A Phase I, Single-Center, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy Subjects.

Trial Profile

A Phase I, Single-Center, Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD7268 After Single Ascending Oral Doses in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Aug 2009

At a glance

  • Drugs AZD 7268 (Primary)
  • Indications Anxiety disorders; Depressive disorders
  • Focus Adverse reactions
  • Most Recent Events

    • 13 May 2009 Actual initiation date (December 2008), actual patient number (48) and actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
    • 13 May 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top